BIOMAT Database Logo BIOMAT Database Logo

Diamminedichloride platinum II and cyclophosphamide in the treatment of advanced urothelial cancer. 1978

A Yagoda, and R C Watson, and N Kemeny, and W E Barzell, and H Grabstald, and W F Whitmore

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009325 Nausea An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses.
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D012075 Remission, Spontaneous A spontaneous diminution or abatement of a disease over time, without formal treatment. Spontaneous Healing,Spontaneous Regression,Spontaneous Remission,Healing, Spontaneous,Regression, Spontaneous,Spontaneous Healings,Spontaneous Regressions
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug

Related Publications

A Yagoda, and R C Watson, and N Kemeny, and W E Barzell, and H Grabstald, and W F Whitmore
Cis-diamminedichloride platinum II in the treatment of advanced bladder cancer.
June 1980, The Journal of urology,
A Yagoda, and R C Watson, and N Kemeny, and W E Barzell, and H Grabstald, and W F Whitmore
Cis-diamminedichloride platinum II (DDP) in the treatment of penile carcinoma.
November 1979, Cancer,
A Yagoda, and R C Watson, and N Kemeny, and W E Barzell, and H Grabstald, and W F Whitmore
Treatment of advanced squamous cell carcinoma of the cervix with cis-platinum (II) diamminedichloride (NSC-119875).
April 1978, American journal of obstetrics and gynecology,
A Yagoda, and R C Watson, and N Kemeny, and W E Barzell, and H Grabstald, and W F Whitmore
Inactivation of bacteriophages with cis-platinum(II) diamminedichloride.
November 1975, Chemico-biological interactions,
A Yagoda, and R C Watson, and N Kemeny, and W E Barzell, and H Grabstald, and W F Whitmore
Cytogenetic effects of cis-platinum(II)diamminedichloride in vivo.
January 1981, Environmental mutagenesis,
A Yagoda, and R C Watson, and N Kemeny, and W E Barzell, and H Grabstald, and W F Whitmore
Cis-platinum-adriamycin-cyclophosphamide in the treatment of advanced-recurrent cervical cancer.
December 1985, The Southeast Asian journal of tropical medicine and public health,
A Yagoda, and R C Watson, and N Kemeny, and W E Barzell, and H Grabstald, and W F Whitmore
The renal pathology in clinical trials of cis-platinum (II) diamminedichloride.
April 1977, Cancer,
A Yagoda, and R C Watson, and N Kemeny, and W E Barzell, and H Grabstald, and W F Whitmore
Chemosensitivity testing with cis-platinum(II) diamminedichloride. II. Preliminary experience in the treatment of carcinoma of the cervix.
February 1982, Gynecologic oncology,
A Yagoda, and R C Watson, and N Kemeny, and W E Barzell, and H Grabstald, and W F Whitmore
[Combination chemotherapy of cyclophosphamide, adriamycin and cisplatin in advanced urothelial cancer].
November 1987, Gan to kagaku ryoho. Cancer & chemotherapy,
A Yagoda, and R C Watson, and N Kemeny, and W E Barzell, and H Grabstald, and W F Whitmore
Cytogenetic effects of cis-platinum(II)diamminedichloride on human lymphocyte cultures.
September 1978, Mutation research,
Copied contents to your clipboard!